Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Xenical Articles

Roche Nearer To Obesity Drug Approval

19 May 1997

European And London Stock Comment

24 April 1997

Roche Enters New Product Phase With Bright Prospects

17 February 1997

Roche Impresses At Analysts' Meeting

17 February 1997

Millennium And Roche See Progress In Obesity Research

27 January 1997

Roche's 1996 Sales Ahead Of Expectations

27 January 1997

Roche Files For Orlistat

9 December 1996

Alizyme Details R&D Strategy And Pipeline

18 November 1996

Roche Highlights Obesity Drug At R&D Conference

21 October 1996

Sales Team Expands At Bristol-Myers Squibb

16 September 1996

1996 First-Half Sales In Line At Roche

22 July 1996

Redux Approved In The USA; Launch In June

6 May 1996

Brussels Probes Roche Austrian "Subsidy"

4 March 1996

Showing 201-213 of 213 articles

Go to beginningPrevious
  • 1
  • 2
  • 3
NextGo to end
  • Hot Topics
  • Most Read
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS